SHP-2 (D50F2) Rabbit Monoclonal Antibody and 1 more item

The University of Virginia awarded contract A207_PO-0448203-V3 to Cell Signaling Technology Inc. on August 8, 2026, for the procurement of specialized research antibodies. The contract, valued at $271, encompasses the delivery of two distinct monoclonal and phospho-antibody products to support the University's research operations in Virginia. The line items consist of 136 units of SHP-2 (D50F2) Rabbit Monoclonal Antibody and 135 units of Phospho-SHP-2 (Tyrosine 542) Antibody, each priced at $1 per unit.

These antibodies are essential reagents for protein research and analysis, with SHP-2 serving as a Src homology 2 domain-containing protein tyrosine phosphatase research tool, while the phospho-variant targets the phosphorylated form of the protein at a specific tyrosine residue. Cell Signaling Technology Inc. has been designated as the prime contractor responsible for fulfilling the delivery obligations to the University of Virginia's designated buyer location. The contract represents a routine procurement of research-grade biological reagents necessary for ongoing laboratory operations and investigative work within the institution's research programs.